EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes

Farima Malekinia, Akram Ahangarpour iD, Khojasteh Hoseinynejad iD, Seyyed Ali Mard iD, Maryam Radan iD, Fereshteh Nejaddehbashi iD

Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)

DOI: 10.1002/edm2.70304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 10.08.2026. Verfasst von Farima Malekinia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Antioxidants, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Inflammation. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes mellitus (T2DM) is strongly associated with oxidative stress and inflammation. Harmaline (HAR), an alkaloid with antioxidant and anti‐inflammatory properties, has been suggested to possess antidiabetic potential. This study investigated the effects of HAR in experimental T2DM and its association with changes in the nuclear factor erythroid 2‐related factor 2 (Nrf2) and nuclear factor kappa‐B (NF‐κB) pathways.

Methods

In vitro experiments were performed using mouse pancreatic cells cultured under different glucose concentrations to evaluate insulin secretion and antioxidant status. For the in vivo study, T2DM was induced in mice by nicotinamide (120 mg/kg) and streptozotocin (65 mg/kg). Fasting blood glucose (FBG) was measured 1 week after induction. Forty‐eight adult male NMRI mice were randomly assigned to four groups: normal control (NC), diabetic control (DC), HAR‐treated (30 mg/kg), and metformin‐treated (150 mg/kg). Treatments were administered once daily for 10 days.

Results

HAR enhanced insulin secretion and antioxidant capacity while reducing lipid peroxidation in vitro. In diabetic mice, HAR significantly reduced FBG, improved the lipid profile, and restored pancreatic antioxidant status. These effects were accompanied by increased expression of miR‐200a, Nrf2, and NAD(P)H: quinone oxidoreductase 1 and reduced Keap1 expression. In addition, HAR increased miR‐125b expression and reduced the expression of NF‐κB, TNF‐α, IL‐1β, and IL‐6. Decreased changes in RAS‐related markers were also observed after HAR treatment.

Conclusion

HAR improved glycemic control and pancreatic antioxidant status and reduced inflammatory responses in experimental T2DM. These beneficial effects were associated with modulation of Nrf2, NF‐κB, and RAS‐related signalling pathways, suggesting their potential involvement in the observed protective effects. Further studies are needed to establish the underlying mechanisms and evaluate the long‐term efficacy and safety of HAR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsDiabetes Mellitus, Type 2Hypoglycemic AgentsInflammationDiabetes Mellitus, ExperimentalAnimalsMaleMiceSignal TransductionNF-kappa BNF-E2-Related Factor 2Oxidative StressOxidation-ReductionBlood GlucoseInsulin

Stichwörter der Autor:innen

harmalineinflammationmale miceoxidative stresstype 2 diabetes

Substanzen

AntioxidantsHypoglycemic AgentsNF-kappa BNF-E2-Related Factor 2Nfe2l2 protein, mouseBlood GlucoseInsulin

Autor:innen und Institutionen

  • Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Akram Ahangarpour, Khojasteh Hoseinynejad, Seyyed Ali Mard, Maryam Radan, Fereshteh Nejaddehbashi

Förderung

  • Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Zitieren

APA

Malekinia, F., Ahangarpour, A., Hoseinynejad, K., Mard, S. A., Radan, M., & Nejaddehbashi, F. (2026). Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70304

Vancouver

Malekinia F, Ahangarpour A, Hoseinynejad K, Mard SA, Radan M, Nejaddehbashi F. Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70304

BibTeX
@article{Malekinia2026,
  author = {Malekinia, Farima and Ahangarpour, Akram and Hoseinynejad, Khojasteh and Mard, Seyyed Ali and Radan, Maryam and Nejaddehbashi, Fereshteh},
  title = {Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {5},
  doi = {10.1002/edm2.70304}
}
Kostenlos starten →